2002-09-14T00:00:00
An advertising watchdog has upheld a complaint against GlaxoSmithKline for claiming that its NiQuitin CQ Lozenges could triple' the chances of quitting smoking. The Advertising Standards Authority ruled that GSK could not substantiate the claim,...
Already have an account? Sign in here
Already have an account? Sign in here
You’ve used up your article allowance